Avanos Medical, Inc. (NYSE:AVNS - Get Free Report)'s share price hit a new 52-week low during trading on Tuesday . The stock traded as low as $17.35 and last traded at $17.63, with a volume of 6665 shares. The stock had previously closed at $17.75.
Analyst Ratings Changes
Separately, StockNews.com cut Avanos Medical from a "strong-buy" rating to a "buy" rating in a research report on Sunday, November 3rd.
Read Our Latest Stock Report on AVNS
Avanos Medical Stock Performance
The company's 50 day moving average price is $20.17 and its 200-day moving average price is $21.43. The stock has a market cap of $782.19 million, a P/E ratio of 51.03 and a beta of 0.95. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22.
Hedge Funds Weigh In On Avanos Medical
Several hedge funds have recently modified their holdings of the company. FMR LLC increased its position in shares of Avanos Medical by 34.6% during the third quarter. FMR LLC now owns 133,844 shares of the company's stock valued at $3,216,000 after acquiring an additional 34,421 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of Avanos Medical by 12.0% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 108,470 shares of the company's stock valued at $2,607,000 after purchasing an additional 11,613 shares during the last quarter. Quest Partners LLC bought a new stake in shares of Avanos Medical during the 2nd quarter worth $444,000. Deerfield Management Company L.P. Series C purchased a new position in shares of Avanos Medical in the 2nd quarter worth about $551,000. Finally, Intech Investment Management LLC bought a new position in Avanos Medical during the third quarter valued at about $207,000. Institutional investors own 95.17% of the company's stock.
About Avanos Medical
(
Get Free Report)
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Featured Stories
Before you consider Avanos Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avanos Medical wasn't on the list.
While Avanos Medical currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
